Weight Loss Drugs arent “the answer”
Sheffield DPH
FEBRUARY 21, 2024
Do Health Economics 101 and read the TA, section 4 esp the discrepancy between manufacturers model assumptions vs committee central base case 3. 2% could be higher depending on the population group who end up taking the drug (when you think about other risk factors for gallstones e.g. women, over 40).
40 
Let's personalize your content